Bioviz Signs Exclusive Partnership for Next-Generation ECM Skin Reviser 'CELIVION'

At the strategic business cooperation and exclusive partnership signing ceremony for the next-generation ECM Skin Reviser 'CELIVION' held at the Allsotech Human R&D Center in Daegu, Allsotech CEO Ilhwan Kim (left) and Biovyju CEO Junho Yang (right) are confirming their commitment to successful market expansion of 'CELIVION.' Provided by Biovyju

Bioviz, a company specializing in medical aesthetics led by CEO Junho Yang, is set to expand its presence in the skin booster market with the next-generation ECM Skin Reviser 'CELIVION'.

On June 22, Bioviz announced that it has entered into a strategic business cooperation and exclusive partnership with Allsotech, a company specializing in medical biomaterials led by CEO Ilhwan Kim. Through this agreement, Bioviz has secured exclusive distribution rights for 'CELIVION', an ECM Skin Reviser based on Acellular Dermal Matrix (hADM) manufactured by Allsotech.

The signing ceremony took place on June 18 at the Allsotech Human R&D Center in Daegu. The event was attended by Bioviz CEO Junho Yang and Deputy CEO Youngje Kim, who is leading the company’s expansion into the ECM sector. The two companies have maintained a collaborative relationship based on a product supply agreement signed last year, and this new exclusive distribution contract marks a significant step forward in their partnership.

CELIVION is a next-generation ECM product that goes beyond the conventional concept of ECM skin boosters for cosmetic purposes, focusing instead on supporting skin tissue recovery and creating an environment conducive to regeneration. It is characterized by enhanced biocompatibility and has been developed as a 'Skin Reviser' product that leverages the functions of the extracellular matrix (ECM) to strengthen skin regeneration effects.

In particular, CELIVION utilizes the 'allo-PELT' process, a low-temperature manufacturing technique, which is recognized for stably preserving the ECM structure and key proteins while improving tissue recovery and regeneration efficiency.

Additionally, 'CELIVION LINJAY', developed through the technical collaboration between Bioviz and Allsotech, features a high collagen content and an ultra-fine, uniform particle design, enhancing the product's regenerative durability and response effects.

Bioviz plans to leverage its in-house branding and marketing capabilities to expand CELIVION’s entry into domestic dermatology and plastic surgery markets. Furthermore, the company aims to pursue global market expansion for CELIVION in stages, utilizing the overseas network established through its existing skin booster and filler businesses.

Ilhwan Kim, CEO of Allsotech, commented, "This exclusive partnership is significant not only as a product supply agreement but also as a strategic collaboration for expanding the application areas of regeneration-based technology together. In addition to broadening the market for our current products, we plan to pursue the development and market introduction of follow-up products step by step, based on the detailed technology roadmap agreed upon by both companies."

Junho Yang, CEO of Bioviz, stated, "With the ECM skin booster market growing rapidly, we expect significant growth compared to last year as sales of ECM Skin Reviser will be added to our existing business areas of medical cosmetics, skincare products, skin boosters, and fillers through our collaboration with Allsotech."

He added, "We will continue to strengthen our competitiveness in both domestic and international markets through ongoing new product development and expansion of our product portfolio."

Based on this exclusive partnership, Bioviz plans to not only expand the domestic and international market for the next-generation ECM Skin Reviser 'CELIVION', but also to enhance its competitiveness in the medical aesthetics business.

This content was produced with the assistance of AI translation services.